Drawing for PHARMAGUARD

USPTO serial 79391761

PHARMAGUARD

Reviewed by CopyMark Law Group

Reg. 7756930Status 700Registered
Filing date
Status date
Registration date
Apr 15, 2025
Examiner
MANCA, ALBERTO I
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PHARMAGUARD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Shoko Naruo

Shoko Naruo Thompson Coburn LLPOne US Bank PlazaSt. Louis, MO 63101United States

Goods and services

ClassDescriptionStatusFirst use
010Containers for medical purposes and for diagnostic purposes, namely, containers for medical waste, containers specially designed for transporting and holding liquid pharmaceuticals; flexible plastic bags and blister packs for medical and pharmaceutical liquids, namely, bags for medical waste, blood collection bags for medical purposes, body fluids collection bags for medical purposes, intravenous bags sold empty for intravenous therapy, plastic blister packs for transmitting liquid medical specimens; flexible plastic bags and blister packs for biological liquids, for medical purposes, namely, bags for medical waste, blood collection bags for medical purposes, body fluids collection bags for medical purposes, intravenous bags sold empty for intravenous therapy, plastic blister packs for transmitting liquid medical specimens; cell culture bags for medical purposes, namely, for cell cultivation; permeable plastic films for medical purposes; drug delivery devices sold empty, namely, bags for use in drug delivery and receptacles for applying medicines; sterile pouches, for medical uses, for the collection and disposal of emesis waste, transmitting medical specimens; pouches, sheaths and containers, for collection of human medical waste in the nature of excretions for medical purposes; bags and case being containers for medical waste, containers especially made for medical wasteACTIVE—
016Plastic material in the nature of pouches, bags, blister packs for packaging; materials for packaging, namely, foils of plastic; printed and unprinted plastic foils for packaging; plastic materials for packaging, namely, foils and foil bags; plastic materials for packaging, namely, vacuum packaging and protective gas filled packaging in the nature of plastic foils, being industrial packaging; plastic materials for packaging, namely, foils, pouches, envelopes, and blister packs; tubular bags for packaging being cardboard tubes for packaging; paper, cardboard and products made from these materials, namely, packages being packaging containers of paper and cardboard and wrapping materials in the nature of wrapping paper; biodegradable packaging, of plastic materials, namely, biodegradable plastic pouches, bags, blister packs for packagingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 16, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 26, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 25, 2026FIMPFINAL DISPOSITION PROCESSED—
Sep 5, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Aug 20, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 20, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jul 15, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 15, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Apr 15, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 7, 2025CHLDCHANGE OF OWNER RECEIVED FROM IB—
Feb 25, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 25, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 19, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 4, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 4, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Feb 4, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 4, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 4, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 3, 2025ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Jan 14, 2025PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Jan 10, 2025ISCRWITHDRAWN FROM ISSUE - OG REVIEW QUERY—
Jan 1, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 27, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Dec 27, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 27, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 27, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 23, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 23, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 23, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 9, 2024ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jul 28, 2024RFNTREFUSAL PROCESSED BY IB—
Jun 27, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 27, 2024RFRRREFUSAL PROCESSED BY MPU—
Jun 14, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 29, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 23, 2024DOCKASSIGNED TO EXAMINER—
Mar 26, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 22, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 21, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance